Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q9TO
|
|||
| Drug Name |
PMID27215781-Compound-12
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH HICKEY, Eugene Richard RIETHER, Doris ERMANN, Monika
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H27N3O4S2
|
|||
| Canonical SMILES |
CC(C)(C)C1=NN=C(S1)NC(=O)C(C)(C)CS(=O)(=O)C2CCOCC2
|
|||
| InChI |
1S/C16H27N3O4S2/c1-15(2,3)13-18-19-14(24-13)17-12(20)16(4,5)10-25(21,22)11-6-8-23-9-7-11/h11H,6-10H2,1-5H3,(H,17,19,20)
|
|||
| InChIKey |
YNOMXHGERFXVDK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 2 (CB2) | Target Info | . | [1] |
| Target's Patent Info | Cannabinoid receptor 2 (CB2) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.Expert Opin Ther Pat. 2016 Jul;26(7):843-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.